Systemic lupus erythematosus (SLE) is associated with the presence of complement proteins and immune complexes in affected organs. Since complement proteins are synthesized in hepatic and extrahepatic sites, we studied a murine model of SLE to ascertain the relative importance of local and humoral (liver) synthesis of complement. C3, C4, and C2 mRNA increase in kidney coincident with the development of nephritis in the MRL lpr/lpr mouse, a strain that spontaneously develops SLE. Two factor B messenger RNA transcripts are expressed in kidney and intestine; SLE nephritis is associated with decrease in the long factor B mKNA and increase in the short form. Increased local synthesis of C3 and I1 protein and a concomitant glomerular and renal interstitial macrophage infiltrate paralleled the increase in mRNA content in the (lpr/ lpr) mice. In addition to kidney, an increase in C3, C4, C2 and factor B mRNA was noted in the lung, heart and intestine and to a lesser extent in liver of (Ipr/lpr) in comparison to the MRL (+/+) animals.
Introduction
The MRL-LP lpr/lpr inbred mouse strain consistently develops a spontaneous murine systemic lupus erythematous (SLE)' syndrome with severe glomerulonephritis and evidence of arteritis in other organs. Lymph gland hyperplasia and arthritis are also common clinical features. Serologic studies show a progressive increase with age, of immunoglobulin concentrations, circulating immune complexes, anti-DNA and other autoantibodies, and a decrease in total serum complement hemolytic activity (1, 2) .
Immune cell infiltration into affected organs is particularly prominent in this murine model of SLE. The expression of 1. Abbreviations used in this paper: SLE, systemic lupus erythematosus. autoimmunity is associated with the emergence of a lymphoid cell population of unusual phenotype (Lyl+-, dThy-l+, L3T4-) (3) . Abnormal immunoregulation by T cells is clearly implicated in the pathogenesis of the disease since depletion of T cells by monoclonal anti-T cell antibody (4) , thymectomy (5) , allogeneic bone marrow transplantation (6) , or treatment with cyclosporin (7) can prevent or ameliorate the systemic autoimmune disease.
In the MRL lpr/lplr mice, as in the human disease, deposits of immunoglobulin and complement components, particularly C3, are identified in the kidney with progression of disease. Activated complement proteins may cause tissue injury directly or recruit inflammatory effector cells (8) .
There is increasing evidence that macrophages have an important role in the pathogenesis of glomerulonephritis. In rat and rabbit experimental models of glomerulonephritis and in the NZB model of murine lupus, mononuclear phagocytes are recruited into the glomerulus during the development of inflammation (9-1 1). The functional role ofthese cells may be regulation of local immune response (they express the Ia antigen and react with lymphocytes in a genetically restricted manner [12] ), clearance of immune complexes (13) , enhancement of tissue injury by release of products such as prostaglandins and leukotrienes (14) and coagulant factors (15) , all of which have been identified in isolated glomerular cultures from rats with glomerulonephritis.
The complement proteins in serum are synthesized by hepatocytes but extrahepatic expression of these proteins in mononuclear phagocytes has been demonstrated as well (16) . In several experimental models, hepatic and extrahepatic regulation of complement gene expression have been shown to be under independent control (17, 18) . To ascertain whether local expression of complement proteins may also play a role in the immunopathology of lupus nephritis, we examined the concentration of mRNA for C3, factor B, C4 and C2 in the kidney and other organs of the MRL lpr/lpr and the congenic MRL +/+ mouse strains at timed intervals. A marked increase in mRNA for these complement proteins in the lpr/lpr kidney and in other organs affected by the autoimmune disease was observed concomitant with the development of SLE. The increased mRNA content is reflected in increased synthesis of complement in the nephritic kidney. Finally, using the F4/80 monoclonal antibody that identifies a specific mouse macrophage antigen (19) , a glomerular and interstitial macrophage infiltrate correlated with progression of the kidney disease.
Methods
Mice. MRL (lpr/lpr) and MRL (+/+) male mice were purchased from the Jackson Laboratory (Bar Harbor, Maine). They were maintained on a regular diet and given water ad lib. Urine for protein analysis was collected from groups of mice in metabolic cages. At four time points, i.e., 6, 12, 18, and 22 wk, mice were killed by cervical dislocation and bled by cardiac puncture, and the liver, kidneys, spleen, lungs, intestine, and heart were rapidly removed. Small slices of liver and kidney were obtained and stored in 10% formalin for histology and quick frozen in liquid nitrogen for immunohistology. The remainder of the organs were frozen in liquid nitrogen and stored at -70'C until processed for isolation of total RNA. Blood was collected into tubes with EDTA and kept on ice, and the separated plasma was stored at -70'C until analyzed for C3, anti-DNA antibody, and creatinine concentrations. Urine protein content was determined by a quantitative sulfosalicylic method (20) . C3 concentration in the plasma was quantitated by immunodiffusion using a rabbit anti-mouse C3 (23) . The C4 probe, a 1.4-kb fragment of the clone pFC4/5.4 (24), and a chicken a-actin cDNA (25) (Table II) . Aged control mice showed a mild glomerular infiltration with macrophages and an insignificant increase in interstitial macrophages. In contrast, lpr/lpr mice displayed increased glomerular macrophages at 6 wk and a marked increase in both glomerular and interstitial macrophages by 18 wk ( Fig. 1 and Table II) . At this time point, the interstitial infiltrate was diffusely peritubular, confined to the cortex, and not associated with tubular necrosis.
Expression of mRNA in kidneys and other organs by Northern blot analysis. As early as 12 wk there was a slight, then progressive, increase in expression of both C3 and C4 mRNA in kidneys of the lpr/lpr strain; in the control MRL +/+ strain, there was a small, but definite increase in C3 and C4 mRNA with advancing age (Fig. 2) . Both C2 and factor B mRNA are constitutively expressed in the kidneys in young animals of both MRL strains. A clear progressive increase in C2 mRNA during the development of glomerulonephritis was seen in the lpr/lpr strain, with only a minimal change noted in the +/+ animal. Factor B mRNA is expressed in the murine kidney as a doublet (reference 17 and Fig. 2 ), the smaller ofthe band decreases. It was not possible to accurately separate the bands for scintillation spectrometry, but laser densitometry clearly showed the presence of the double band, a twofold increase of the lower band and a > 80% fold decrease of the upper band with advancing age in the lpr/lpr strain (Figs. 2 and  3 ). Ofall the other organs examined, only the intestine displays the double-banded factor B mRNA.
Synthetic oligomers homologous to C4 and Slp sequence were used to determine whether the Slp sequence of the C4 gene was expressed in the kidney ofthis mouse strain. Only the sequence homologous to C4 hybridized to kidney mRNA at 18 and 22 wk in the lpr/lpr strain. No hybridization to kidney mRNA was observed with the Slp oligomer, but a strong signal was obtained when, for a control, a plasmid containing the Slp cDNA was probed with the Slp specific oligonucleotide (results not shown).
The expression of complement genes in other organs ofthe +/+ and lpr/lpr strain was estimated at 18 wk by Northern blot analysis as shown in Fig. 4 . For liver, the source ofplasma complement, the mRNA content of C2, C3, C4, and factor B in lpr/lpr was approximately twofold that of each in the +/+ strain (Fig. 4 ). There were no marked differences between the two strains in expression of these mRNA species in the spleen. However, a comparison of lung, heart and intestine in the two strains revealed substantially more mRNA in the lpr/lpr than in the +/+ strain at 18 wk.
Loading of the gels for Northern blotting was initially estimated by comparing ethidium bromide staining of the 28S and 18S RNA bands. The chicken a-actin cDNA probe which cross-hybridizes with both # and T-actin was used to more C4 04,. 28s-18s-L V Vv V \ K S Lu I H precisely estimate comparability of the data. Actin mRNA concentrations varied among the different organs, however, similar amounts were present for each organ in comparing the two mouse strains (Fig. 5 ).
Protein synthesis in kidney. Mice ages 6 and 18 wk of the congenic strains were used to study the biosynthesis offactor B and C3. Tissues were cultured for 1 h after an initial 20-min labeling period. Only the kidney specimens derived from the 1 8-wk old lpr/lpr strain synthesized significant amounts of C3 and factor B protein (Fig. 6) . The majority of labeled C3 protein was expressed as pro-C3 with trace amounts of native C3 detectable, as expected, in the intracellular compartment.
Discussion
We have demonstrated a progressive increase in mRNA corresponding to the complement genes C3, C4, C2, and factor B in the kidney ofthe MRL lpr/lpr mouse strain coincident with the development of glomerulonephritis and interstitial nephritis. This mRNA is translated, since kidney organ cultures derived from mice with glomerulonephritis manifested increased biosynthesis of C3 (27) . Although increases in complement-specific mRNA and protein synthesis during the evolution of nephritis correlated with increased numbers of macrophages, attribution of the observed changes to a specific cell type must remain speculative. That is, it is possible that the different factor B mRNA species are derived from different cells within the same organ. Indeed, such a mechanism has recently been described for expression of the human a-1 proteinase inhibitor gene. Macrophages and hepatocytes express ac-l proteinase inhibitor, but two mRNA species are found in macrophages (28), both of which are larger than the hepatocellular a-1 PI mRNA. In each cell different promoter sequences have been identified. An alternative splicing mechanism apparently accounts for the two forms of mRNA found in the macrophage (29). In immune complex glomerulonephritis, hypercellularity can be attributed to macrophage infiltration and to proliferation of intrinsic glomerular cells, particularly mesangial cells. Macrophages (30) v r factor B in kidney and intestine or a more complex mechanism of regulation of the two forms of B mRNA must exist.
The F4/80 membrane antigen is a specific marker of mouse macrophages (19) . We have used monoclonal antibody to this antigen to demonstrate that in this mouse model of immune complex glomerulonephritis, macrophages infiltrate the glomerulus and the interstitium, where they are the predominant inflammatory cell. Macrophages produce complement locally and monokines may act on adjacent cells. The regulation ofcomplement biosynthesis by the monokines IL-1 and TNF in mouse and human hepatocytes has been well documented. The effect of these monokines is exerted at a pretranslational level, selectively upregulating factor B, C3 and C4 but not C2 (31) (32) (33) . However, in vivo administration of rIL-1 increases renal concentrations of C2, C3 and factor B mRNA (17) . The distinct pattern in this SLE model of increased mRNA of all the complement components we studied suggests a common mediator of this upregulation. In vitro studies with recombinant IFN-y have shown that it enhances the mRNA and synthesis of C2, B, C3 and C4 in mononuclear phagocytes (33) . In this regard, it is of interest that in vivo administration of IFN-y aggravates, while ablation of T lymphocyte function ameliorates, progression of murine SLE (34, 35) .
In acute immune complex kidney disease, circulating immune complexes are deposited within the subendothelial and mesangial regions of the glomerulus. Serum complement concentration decreases and local activation of the complement cascade occurs (36). Activation of complement leads to recruitment of other inflammatory cells and enhanced opsonization of immune complexes. In addition, components of the classical complement pathway inhibit immune complex deposition and enhance solubilization of immune complexes (37, 38) . Hence, local production of complement may significantly modify the evolution of immune nephritis. Our studies demonstrate that increased local production of complement also occurs in the kidney coincident with the development of glomerulonephritis and interstitial nephritis. Thus, in situ renal synthesis of complement proteins may exacerbate or protect against immune complex mediated tissue injury.
